About
Michael Hamblin is a leading researcher in photobiomodulation (red light therapy) at Harvard Medical School and MIT. He has published over 500 papers on the topic and is considered one of the foremost experts in the field.
His research has elucidated the mechanisms by which red and near-infrared light affect cellular function, particularly through cytochrome c oxidase in the mitochondrial electron transport chain.
Areas of Expertise
Notable Work
Hamblin (2016) - Photobiomodulation for brain disorders
Over 500 publications on light therapy